Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Total Liabilities (2016 - 2025)

Medifast (MED) has disclosed Total Liabilities for 16 consecutive years, with $49.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 33.81% year-over-year to $49.1 million, compared with a TTM value of $49.1 million through Dec 2025, down 33.81%, and an annual FY2025 reading of $49.1 million, down 33.81% over the prior year.
  • Total Liabilities was $49.1 million for Q4 2025 at Medifast, down from $53.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $211.1 million in Q2 2022 and bottomed at $49.1 million in Q4 2025.
  • Average Total Liabilities over 5 years is $126.4 million, with a median of $130.1 million recorded in 2023.
  • The sharpest move saw Total Liabilities skyrocketed 65.77% in 2021, then crashed 39.57% in 2025.
  • Year by year, Total Liabilities stood at $195.9 million in 2021, then decreased by 17.71% to $161.2 million in 2022, then tumbled by 32.72% to $108.4 million in 2023, then crashed by 31.66% to $74.1 million in 2024, then plummeted by 33.81% to $49.1 million in 2025.
  • Business Quant data shows Total Liabilities for MED at $49.1 million in Q4 2025, $53.5 million in Q3 2025, and $53.3 million in Q2 2025.